Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 5c, Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Hims & Hers Health, Inc. Reports Second Quarter 2021 Financial Results
August 11, 2021 4:05 PM EDTQ2 2021 revenue grows 69% year-over-year to $60.7 million
Q2 2021 online revenue grows 75% year-over-year to $58.1 million
Exceeds Q2 2021 guidance, raises full year 2021 expectations
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the second quarter ending June 30, 2021.
"This was a quarter of very strong execution, as we continued to drive consistent organic revenue growth across our business, from our core... More



